Budget Impact of the 14-Gene Risk-Score (RS) Assay to Inform Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
May 1, 2014, 00:00
10.1016/j.jval.2014.03.432
https://www.valueinhealthjournal.com/article/S1098-3015(14)00483-5/fulltext
Title :
Budget Impact of the 14-Gene Risk-Score (RS) Assay to Inform Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer (NSCLC)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)00483-5&doi=10.1016/j.jval.2014.03.432
First page :
A74
Section Title :
Cancer
Open access? :
No
Section Order :
1478